Impact of Discontinuation of Denosumab on Bone Health in Breast Cancer Patients

被引:0
|
作者
Tannenbaum, Susan
Soto, Alvaro Alvarez
Taxel, Pamela
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO1-12-02
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO1-12-02
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Bone Health and Denosumab Discontinuation in Oncology Populations
    Cheung, Yee-Ming Melody
    Morgans, Alicia
    Hamnvik, Ole-Petter Riksfjord
    ONCOLOGIST, 2022, 27 (12): : 998 - 1003
  • [2] Impact of denosumab on bone mass in cancer patients
    Brown-Glaberman, Ursa
    Stopeck, Alison T.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 117 - 129
  • [3] Denosumab in the Treatment of Breast Cancer Patients with Bone Metastasis
    Steger, Guenther
    Bartsch, Rupert
    Fridrik, Michael A.
    Gampenrieder, Simon P.
    Marth, Christian
    BREAST CARE, 2016, 11 (05) : 363 - 365
  • [4] Impact of aromatase inhibitors on bone health in breast cancer patients
    Geisler, Jurgen
    Lonning, Per E.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (4-5): : 294 - 299
  • [5] Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis
    Zeytinoglu, Meltem
    Naaman, Sandra C.
    Dickens, Laura T.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2021, 50 (02) : 205 - 222
  • [6] Treatment of bone metastatic breast cancer patients with denosumab in real life
    Irelli, A.
    Cocciolone, V.
    Cannita, K.
    Zugaro, L.
    Di Staso, M.
    Baldi, P. Lanfiuti
    Paradisi, S.
    Sidoni, T.
    Ficorella, C.
    Ricevuto, E.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S45 - S45
  • [7] Denosumab in the treatment of breast cancer bone metastases
    Lipton, A.
    Paterson, A.
    Tonkin, K.
    Gao, G.
    Kinsey, A. C.
    Jun, S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 18 - 18
  • [8] Effect of risedronate on bone loss at discontinuation of denosumab
    Laroche, Michel
    Couture, Guillaume
    Ruyssen-Witrand, Adeline
    Constantin, Arnaud
    Degboe, Yannick
    BONE REPORTS, 2020, 13
  • [9] EFFECTS OF DENOSUMAB DISCONTINUATION ON BONE HISTOLOGY AND HISTOMORPHOMETRY
    Brown, J. P.
    Dempster, D. W.
    Ding, B.
    Dent, R.
    San Martin, J.
    Wagman, R. B.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 134 - 135
  • [10] A Retrospective Analysis of Denosumab for the Treatment of Bone Metastases in Chinese Patients With Breast Cancer
    Li, Wei
    Wu, Xinyu
    Yu, Heng
    Zhu, Zekai
    Li, Wenjie
    Huang, Xiang
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17